211 related articles for article (PubMed ID: 15996549)
1. Mechanism of partial agonist action at the NR1 subunit of NMDA receptors.
Inanobe A; Furukawa H; Gouaux E
Neuron; 2005 Jul; 47(1):71-84. PubMed ID: 15996549
[TBL] [Abstract][Full Text] [Related]
2. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
3. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
Laube B; Schemm R; Betz H
Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
[TBL] [Abstract][Full Text] [Related]
5. Tweaking agonist efficacy at N-methyl-D-aspartate receptors by site-directed mutagenesis.
Hansen KB; Clausen RP; Bjerrum EJ; Bechmann C; Greenwood JR; Christensen C; Kristensen JL; Egebjerg J; Bräuner-Osborne H
Mol Pharmacol; 2005 Dec; 68(6):1510-23. PubMed ID: 16131614
[TBL] [Abstract][Full Text] [Related]
6. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
[TBL] [Abstract][Full Text] [Related]
7. Ligand-binding residues integrate affinity and efficacy in the NMDA receptor.
Kalbaugh TL; VanDongen HM; VanDongen AM
Mol Pharmacol; 2004 Aug; 66(2):209-19. PubMed ID: 15266011
[TBL] [Abstract][Full Text] [Related]
8. Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site.
Wafford KA; Kathoria M; Bain CJ; Marshall G; Le Bourdellès B; Kemp JA; Whiting PJ
Mol Pharmacol; 1995 Feb; 47(2):374-80. PubMed ID: 7870047
[TBL] [Abstract][Full Text] [Related]
9. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
10. Subunit arrangement and function in NMDA receptors.
Furukawa H; Singh SK; Mancusso R; Gouaux E
Nature; 2005 Nov; 438(7065):185-92. PubMed ID: 16281028
[TBL] [Abstract][Full Text] [Related]
11. Principal role of NR3 subunits in NR1/NR3 excitatory glycine receptor function.
Madry C; Mesic I; Bartholomäus I; Nicke A; Betz H; Laube B
Biochem Biophys Res Commun; 2007 Mar; 354(1):102-8. PubMed ID: 17214961
[TBL] [Abstract][Full Text] [Related]
12. Specificity of putative partial agonist, 1-aminocyclopropanecarboxylic acid, for rat N-methyl-D-aspartate receptor subunits.
Sheinin A; Nahum-Levy R; Shavit S; Benveniste M
Neurosci Lett; 2002 Jan; 317(2):77-80. PubMed ID: 11755244
[TBL] [Abstract][Full Text] [Related]
13. Disruption of agonist and ligand activity in an AMPA glutamate receptor splice-variable domain deletion mutant.
Johnson WD; Parandaman V; Onaivi ES; Taylor RE; Akinshola BE
Brain Res; 2008 Jul; 1222():18-30. PubMed ID: 18585685
[TBL] [Abstract][Full Text] [Related]
14. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
Jin R; Gouaux E
Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
[TBL] [Abstract][Full Text] [Related]
15. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
16. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
18. Dopamine D1 receptors co-distribute with N-methyl-D-aspartic acid type-1 subunits and modulate synaptically-evoked N-methyl-D-aspartic acid currents in rat basolateral amygdala.
Pickel VM; Colago EE; Mania I; Molosh AI; Rainnie DG
Neuroscience; 2006 Oct; 142(3):671-90. PubMed ID: 16905271
[TBL] [Abstract][Full Text] [Related]
19. Characterisation of the human NMDA receptor subunit NR3A glycine binding site.
Nilsson A; Duan J; Mo-Boquist LL; Benedikz E; Sundström E
Neuropharmacology; 2007 Mar; 52(4):1151-9. PubMed ID: 17320117
[TBL] [Abstract][Full Text] [Related]
20. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor by the anesthetics xenon and isoflurane: evidence from molecular modeling and electrophysiology.
Dickinson R; Peterson BK; Banks P; Simillis C; Martin JC; Valenzuela CA; Maze M; Franks NP
Anesthesiology; 2007 Nov; 107(5):756-67. PubMed ID: 18073551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
